Specialty code 183500000X · Lancaster, CA
NPI
1992254544
Since 2016
Specialty
Specialty code 183500000X
Code 183500000X
Group practices
0
Medicare group memberships
Hospitals
0
Hospital affiliations
615 W Avenue L
Lancaster, CA, 93534
Phone (619) 641-2548
Medicare paid
-
No Medicare services published
Medicare patients
-
Drug cost, 2024
$189K
952 prescriptions
Company payments
-
None reported
Medicare prescription drug claims, 2024
In 2024, the drug Marie D Hovsepian prescribed most often to Medicare patients was Metformin Hcl Er (Metformin Hcl), with 113 prescriptions and refills. In total Marie D Hovsepian wrote 952 Medicare prescriptions that cost $189K.
| Drug |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2016-09-23.
| Claims |
|---|
| 30-day fills |
|---|
| Patients |
|---|
| Cost |
|---|
| Metformin Hcl Er Metformin Hcl | 113 | 367 | 50 | $1,104 |
| Nano 2nd Gen Pen Needle Pen Needle, Diabetic | 87 | 273 | 45 | $2,574 |
| Humulin 70/30 Kwikpen Insulin Nph Hum/Reg Insulin Hm | 87 | 250 | 38 | $31K |
| Humulin N Kwikpen Insulin Nph Human Isophane | 84 | 221 | 37 | $16K |
| Insulin Glargine-Yfgn Generic | 73 | 216 | 41 | $12K |
| Ozempic Semaglutide | 70 | 72 | 16 | $53K |
| Metformin Hcl Generic | 66 | 219 | 32 | $860 |
| Glipizide Generic | 60 | 198 | 32 | $821 |
| Humulin N Insulin Nph Human Isophane | 58 | 175 | 29 | $11K |
| Veo Insulin Syringe Syringe-Needle,insulin,0.5 Ml | 30 | 93 | 18 | $814 |
| Veo Insulin Syringe Syringe And Needle,insulin,1ml | 28 | 74 | 16 | $743 |
| Humulin 70-30 Insulin Nph Hum/Reg Insulin Hm | 27 | 81 | 14 | $5,292 |
| Jardiance Empagliflozin | 22 | 73 | 12 | $15K |
| Humalog Kwikpen U-100 Insulin Lispro | 21 | 59 | Under 11 | $7,925 |
| Victoza 2-Pak Liraglutide | 21 | 25 | Under 11 | $16K |
Brand drugs: 509 claims; generic drugs: 261 claims.
Money and other things of value reported by the companies
No payments from drug or medical device companies to Marie D Hovsepian were reported in the years we have.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.